Lapatinib is a promising new breast cancer medication. It is an oral therapy targeting intracellular components of a receptor known as ErbB2 and a second receptor, ErbB1, which have been implicated in the growth of various tumor types. Early tests have shown excellent results in treatment of breast cancer, and researchers hope to try Lapatinib on other solid tumor cancers. Chemical Name: N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl] quinazolin-4-amine Bis(4-methylbenzenesulfonate) monohydrate Appearance: Yellow crystalline powder.
CAS No.: [388082-78-8]
Identification: H-1 NMR spectrum-Conforms.
Melting Point: Min240℃ (decompose)
Water:1.5%-2.5%.
Price is per:
Price - Volume Description
Please Select
Country Of Origin
What is the Country of Origin?
-
Specifications
Which lab did the Testing on these Raw Materials?
-
Testing Method used?
-
What instrumentation was used?
-
Validated to what?
-
Was Micro Testing Done?
-
Mirco Testing Results
-
Where these raw materials tested for heavy Metals?
-
Heavy Metal Test Results
-
Certificate Of Analysis
Certificate of Analysis uploaded for Bidders review?
-
Do you Have a C of A for these Raw Materials?
Certifications
Are these products cGMP certified? If so by who?
-
If other then who?
-
Purity Guarantee
Money Back if testing does not meet or exceed C of A data?
-
Herbs
Is this an Herb?
-
Type
-
Is a Standerized claim Being made?
Method: - Results?: -
Item viewed 54 times
Ask Seller a Question
Please login in order to ask the seller a question.
Offline Payment
Wire Transfer
Shipping
Shipping Conditions
Seller pays for shipping expenses
Domestic Postage
-
Worldwide Postage
-
Insurance
-
Shipping Method
Freight
The poster, yxpharm, assumes all responsibility for the contents of this listing
